These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7532100)

  • 1. In vitro assessment of compounds for anti-HIV activity.
    Patience C; Moore J; Boyd M
    Mol Biotechnol; 1994 Feb; 1(1):49-58. PubMed ID: 7532100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase substrate depletion: a novel strategy for inhibiting the replication of the human immunodeficiency virus.
    Ichimura H; Levy JA
    Virology; 1995 Aug; 211(2):554-60. PubMed ID: 7544050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear localization signal of HIV-1 as a novel target for therapeutic intervention.
    Dubrovsky L; Ulrich P; Nuovo GJ; Manogue KR; Cerami A; Bukrinsky M
    Mol Med; 1995 Jan; 1(2):217-30. PubMed ID: 8529100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and simple colorimetric test for the study of anti-HIV agents.
    Schwartz O; Henin Y; Marechal V; Montagnier L
    AIDS Res Hum Retroviruses; 1988 Dec; 4(6):441-8. PubMed ID: 2464361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral action of oligodeoxyguanylic acids against human immunodeficiency virus type 1.
    Fujihashi T; Sakata T; Kaji A; Kaji H
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):461-71. PubMed ID: 7543270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.
    Hayashi S; Norbeck DW; Rosenbrook W; Fine RL; Matsukura M; Plattner JJ; Broder S; Mitsuya H
    Antimicrob Agents Chemother; 1990 Feb; 34(2):287-94. PubMed ID: 2327778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
    Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
    J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of triciribine and triciribine-5'-monophosphate against human immunodeficiency virus types 1 and 2.
    Kucera LS; Iyer NP; Puckett SH; Buckheit RW; Westbrook L; Toyer BR; White EL; Germany-Decker JM; Shannon WM; Chen RC
    AIDS Res Hum Retroviruses; 1993 Apr; 9(4):307-14. PubMed ID: 7685612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
    Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
    Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.
    De Clercq E; Yamamoto N; Pauwels R; Baba M; Schols D; Nakashima H; Balzarini J; Debyser Z; Murrer BA; Schwartz D
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5286-90. PubMed ID: 1608936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tubeimoside-1 on HIV core protein p24 and cytopathogenesis in vitro.
    Yu LJ; Ma RD; Jiang SB
    Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):103-6. PubMed ID: 8010099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.
    Nakashima H; Masuda M; Murakami T; Koyanagi Y; Matsumoto A; Fujii N; Yamamoto N
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1249-55. PubMed ID: 1384424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative.
    Baba M; Tanaka H; De Clercq E; Pauwels R; Balzarini J; Schols D; Nakashima H; Perno CF; Walker RT; Miyasaka T
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1375-81. PubMed ID: 2575380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
    Montefiori DC; Zhou JY
    Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Evans blue and trypan blue on syncytia formation and infectivity of human immunodeficiency virus type I and type II in vitro.
    Pal R; Mumbauer S; Hoke G; Larocca R; Myers C; Sarngadharan MG; Stein CA
    AIDS Res Hum Retroviruses; 1991 Jun; 7(6):537-43. PubMed ID: 1718343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase.
    Moore PS; Jones CJ; Mahmood N; Evans IG; Goff M; Cooper R; Hay AJ
    Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):129-34. PubMed ID: 7536411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates.
    Eron JJ; Gorczyca P; Kaplan JC; D'Aquila RT
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3241-5. PubMed ID: 1565615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    McMahon JB; Gulakowski RJ; Weislow OS; Schultz RJ; Narayanan VL; Clanton DJ; Pedemonte R; Wassmundt FW; Buckheit RW; Decker WD
    Antimicrob Agents Chemother; 1993 Apr; 37(4):754-60. PubMed ID: 7684215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.